Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies

Background The recommended dose of rasburicase is quite expensive, thus limiting its use. Whether a lower dose of rasburicase would be equally effective for critically ill children, who often have more complicated situations and a higher risk of hospital death, is still unknown. Objective To explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Yuxin, Li, Yu, Liang, Yujian, Xu, Lingling, Huang, Xueqiong, Li, Yijuan, Tang, Wen, Jiang, Xiaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603475/
https://www.ncbi.nlm.nih.gov/pubmed/32974856
http://dx.doi.org/10.1007/s11096-020-01144-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603475/
https://www.ncbi.nlm.nih.gov/pubmed/32974856
http://dx.doi.org/10.1007/s11096-020-01144-8

Ejemplares similares